Charles River and Autolomous partner to transform laboratory execution systems
Partnership reinforces continued investment in digitization, automation, and client-facing transparency
Partnership reinforces continued investment in digitization, automation, and client-facing transparency
The high molecular quality of these FFPE tissue samples provides scientists with the highest confidence in derived data quality
Genome Detective and Oxford Nanopore sequencing used to track the spread and evolution of tomato leaf curl New Delhi virus in France, enabling scalable plant-virus surveillance and epidemiological insights
What if you could watch living cells for days, or follow them at 100,000 frames per second, without adding a single marker?
Leandro Neves, Senior Global Director of R&D Genomics at LGC, discusses the technologies, challenges, and opportunities shaping the future of genomic analysis
Tell us which new products have had the biggest impact on your lab work for a chance to win one of four $100 Amazon.com Gift Cards
Collaboration combines CellCarta’s global clinical trial testing capabilities with Waters’ standardized flow cytometry platforms and expertise
New Phoenix laboratory expands Vitalant’s CGT analytics network with additional donor characterization and immune profiling capabilities
Initial work will examine the potential of Vitrafy’s technology to extend platelet preservation to support a more resilient blood supply
New cGMP-ready media and feed panel helps developers rapidly identify high-performing combinations
Q&A with Microbiology in Health and Disease Lead Editor Liang Wang at the Journal of Applied Microbiology
Discover how the HeadSMART II study is combining blood biomarkers, digital neurocognitive testing and AI to identify patients at risk of persistent TBI symptoms
An analysis of data from more than 33,000 women found that breast density could partially explain the link between a higher body weight at age 20 and a lower chance of post-menopausal breast cancer
Dr. Vasiliki E. Kalodimou on women in STEM, global collaboration, and the next era of regenerative medicine
New Ancora assays for oncology produce precision results with MRD-grade sensitivity, delivering the full biological picture for every sample
New portfolio aims to support biosimilar developers accelerate the path to analytical similarity and improve process economics
Guest editorial by Maya Carlyle, Principal AI Engineer at the National Physical Laboratory (NPL)
Acquisition advances Leica Biosystems’ end-to-end anatomic pathology ecosystem, expanding integrated solutions that help laboratories move from sample to answer with speed and confidence for the clinicians and patients who depend on them
A new bench-top bioreactor platform with process control designed to support GMP-ready environments from 100 mL to 10 L working volume
Guest editorial by Russ Lebovitz, MD, PhD, is CEO and Co-Founder of Amprion
As Gram-negative resistance becomes more complex, laboratories and clinicians are working together to turn susceptibility data into more targeted treatment decisions
Delivering reduced hands-on time, more consistent results, and higher sample throughput
The non-invasive test could help clinicians identify women needing urgent hospital investigations while reassuring those unlikely to have womb cancer
Every cell biologist knows the feeling of staring at two identical experiments with different outcomes and wondering whether the answer lies in the biology or the handling
New cGMP-ready media and feed panel helps developers rapidly identify high-performing combinations, with study results demonstrating up to 73% higher titer versus benchmark catalog media and feeds and up to 202% higher peak viable cell density compared with benchmark products tested